Page 4 - பல அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பல அமைப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பல அமைப்பு Today - Breaking & Trending Today

Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial


Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial
Highlights:
Alterity receives positive guidance from the European Medicines Agency’s Committee for Medicinal Products for Human Use on its Phase 2 clinical trial for Multiple System Atrophy.
Concurrence with Alterity’s plan to target early stage MSA patients.
Endorsement on selection of biomarker endpoints to assess pathological hallmarks of MSA.
Agreement that ATH434 has potential as a disease modifying treatment.
MELBOURNE, Australia and SAN FRANCISCO, June 23, 2021 /PRNewswire/ Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ( Alterity or the Company ) has received guidance from the European Medicines Agency
(EMA) regarding key aspects of the Company’s Phase 2 clinical trial for investigational drug ATH434 in the treatment of Multiple System Atrophy (MSA). ....

David Stamler , Company Phase , Vanderbilt University Medical Center , Drug Administration , European Union , European Medicines Agency , Alterity Therapeutics Limited , Alterity Therapeutics , Medicinal Products , Human Use , Multiple System , Multiple System Atrophy , History Study , Progressive Supranuclear Palsy , நிறுவனம் கட்டம் , வாண்டர்பில்ட் பல்கலைக்கழகம் மருத்துவ மையம் , ஐரோப்பிய தொழிற்சங்கம் , மருத்துவ ப்ராடக்ட்ஸ் , மனிதன் பயன்பாடு , பல அமைப்பு , பல அமைப்பு அட்ரோஃபீ , வரலாறு படிப்பு ,